a 68930 has been researched along with sk&f 85174 in 1 studies
| Studies (a 68930) | Trials (a 68930) | Recent Studies (post-2010) (a 68930) | Studies (sk&f 85174) | Trials (sk&f 85174) | Recent Studies (post-2010) (sk&f 85174) |
|---|---|---|---|---|---|
| 63 | 2 | 19 | 9 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grenader, A; Healy, DP | 1 |
1 other study(ies) available for a 68930 and sk&f 85174
| Article | Year |
|---|---|
A68930 is a potent, full agonist at dopamine1 (D1) receptors in renal epithelial LLC-PK1 cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Benzazepines; Cells, Cultured; Chromans; Cyclic AMP; Dopamine; Dopamine Agents; Epithelial Cells; Epithelium; Fenoldopam; Kidney; Receptors, Dopamine D1 | 1992 |